Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection RB Fulton, DK Meyerholz, SM Varga The Journal of Immunology 185 (4), 2382-2392, 2010 | 290 | 2010 |
The TCR's sensitivity to self peptide–MHC dictates the ability of naive CD8+ T cells to respond to foreign antigens RB Fulton, SE Hamilton, Y Xing, JA Best, AW Goldrath, KA Hogquist, ... Nature immunology 16 (1), 107, 2015 | 218 | 2015 |
Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection KA Weiss, AF Christiaansen, RB Fulton, DK Meyerholz, SM Varga The Journal of Immunology 187 (6), 3145-3154, 2011 | 137 | 2011 |
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity EM Tam, RB Fulton, JF Sampson, M Muda, A Camblin, J Richards, ... Science translational medicine 11 (512), eaax0720, 2019 | 42 | 2019 |
Effects of aging on the adaptive immune response to respiratory virus infections RB Fulton, SM Varga Aging health 5 (6), 775-787, 2009 | 42 | 2009 |
Regulation of cytokine production by virus-specific CD8 T cells in the lungs RB Fulton, MR Olson, SM Varga Journal of virology 82 (16), 7799-7811, 2008 | 41 | 2008 |
Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection RB Fulton, KA Weiss, LL Pewe, JT Harty, SM Varga Journal of virology 87 (23), 12694-12700, 2013 | 39 | 2013 |
T cell epitope specificity and pathogenesis of mouse hepatitis virus-1–induced disease in susceptible and resistant hosts A Khanolkar, RB Fulton, LL Epping, NL Pham, D Tifrea, SM Varga, ... The Journal of Immunology 185 (2), 1132-1141, 2010 | 33 | 2010 |
L]. Kienker,]. R RJ Fulton, RL McDade, PL Smith Kettman Jr., Clin. Chem 43, 1749, 1997 | 18* | 1997 |
Synergy between EphA2-ILs-DTXp, a novel EphA2-targeted nanoliposomal taxane, and PD-1 inhibitors in preclinical tumor models WS Kamoun, AS Dugast, JJ Suchy, S Grabow, RB Fulton, JF Sampson, ... Molecular Cancer Therapeutics 19 (1), 270-281, 2020 | 16 | 2020 |
Immune pharmacodynamic responses of the novel cancer immunotherapeutic Imprime PGG in healthy volunteers N Bose, NR Ottoson, X Qiu, B Harrison, JR Lowe, MT Uhlik, BT Rathmann, ... The Journal of Immunology 202 (10), 2945-2956, 2019 | 11 | 2019 |
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016 A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ... Journal for immunotherapy of cancer 4, 1-106, 2016 | 10 | 2016 |
31st annual meeting and associated programs of the society for immunotherapy of cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016 S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ... Journal for ImmunoTherapy of Cancer 4, 223-242, 2016 | 9 | 2016 |
Imprime PGG triggers PD-L1 expression on tumor and myeloid cells and prevents tumor establishment in combination with αPD-L1 treatment in vivo K Fraser, A Chan, R Fulton, S Leonardo, A Jonas, X Qiu, N Ottoson, ... Cancer Research 76 (14_Supplement), 2335-2335, 2016 | 9 | 2016 |
CD8+ T cell self-tolerance permits responsiveness but limits tissue damage EN Truckenbrod, KS Burrack, TP Knutson, H Borges da Silva, KE Block, ... Elife 10, e65615, 2021 | 8 | 2021 |
Imprime PGG decreases regulatory T cell suppression and enhances T cell proliferation and differentiation revealing additional mechanisms for its anti-tumor activity SM Leonardo, K Gorden, R Fulton, L Wurst Cancer Research 75 (15_Supplement), 5034-5034, 2015 | 8 | 2015 |
Imprime PGG enhances anti-tumor effects of tumor-targeting, anti-angiogenic, and immune checkpoint inhibitor antibodies ASH Chan, TO Kangas, X Qiu, MT Uhlik, RB Fulton, NR Ottoson, ... Frontiers in Oncology 12, 869078, 2022 | 7 | 2022 |
Abstract B019: Imprime PGG, a soluble β-glucan, binds to and activates dendritic cells resulting in enhanced T cell priming, expansion, and cytokine production RB Fulton, SM Leonardo, KS Michel, ME Danielson, KB Gorden, JR Graff Cancer Immunology Research 4 (1_Supplement), B019-B019, 2016 | 7 | 2016 |
A novel human TNFR2 antibody (MM-401) modulates T cell responses in anti-cancer immunity JF Sampson, VB Kurella, V Paragas, S Kumar, JE Lulo, JA Qiu, M Razlog, ... Cancer Res 79 (13 Supplement), 555, 2019 | 6 | 2019 |
MM-401, a novel anti-TNFR2 antibody that induces T cell co-stimulation, robust anti-tumor activity and immune memory J Richards, C Wong, A Koshkaryev, R Fulton, A Camblin, J Sampson, ... Cancer Res 79 (13 Supplement), 4846, 2019 | 6 | 2019 |